Immatics N.V.

IMTX47

$11.73arrow_drop_up2.62%$0.30

IMTX47

$11.73

arrow_drop_up2.62%$0.30

Performance History

Key Stats
Open	$11.49
Prev. Close	$11.43
EPS	-0.92
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	11.20	11.78
52 Week Range	7.15	13.77

Ratios







EPS	-0.92

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Immatics N.V. (IMTX)

Immatics N.V. (IMTX) is a biopharmaceutical company focused on the development of innovative immunotherapies for the treatment of cancer. The company uses its proprietary technology platform to identify and prioritize targets for T cell receptor (TCR) based therapies. These therapies aim to harness the power of the immune system to recognize and destroy tumor cells. Immatics N.V. is currently advancing a pipeline of TCR-based product candidates targeting a range of cancer indications.

In terms of stock price history, Immatics N.V. (IMTX) went public on the NASDAQ Global Select Market on July 21, 2020. Since then, the stock price has shown both ups and downs, mirroring the volatility often associated with biopharmaceutical companies. However, Immatics N.V. has been focused on advancing its pipeline and has made significant progress in its clinical programs.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Harpreet Singh Ph.D.
Headquarters: Tübingen
Employees: 402
Exchange: NASDAQ

Keep an eye on Immatics N.V.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the 52-week high and low for Immatics N.V. (IMTX)?

For Immatics N.V. (IMTX), the 52-week high is $13.77, which is 17.39% from the current price. The 52-week low is $7.15, the current price is 64.06% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

What is Immatics N.V.'s (IMTX) price per share?

The current price per share for Immatics N.V. (IMTX) is $11.73. The stock has seen a price change of $0.3 recently, indicating a 2.62% change. This reflects the stock's recent market performance and investor sentiment.

help

Is Immatics N.V. (IMTX) a growth stock?

Immatics N.V. (IMTX) has shown an average price growth of 0.41% over the past three years. It has received a score of 52 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Immatics N.V. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Immatics N.V. (IMTX) stock price performance year to date (YTD)?

As of the latest data, Immatics N.V. (IMTX) has a year-to-date price change of 9.42%. Over the past month, the stock has experienced a price change of 2.89%. Over the last three months, the change has been -8.93%. Over the past six months, the figure is -4.4%.

help

Is Immatics N.V. (IMTX) a profitable company?

Immatics N.V. (IMTX) has a net income of -$96.99M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -141.64% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $54M, although specific revenue growth data is currently not available. Operating income is noted at -$101.72M. Furthermore, the EBITDA is -$105.53M.

help

What is the market capitalization of Immatics N.V. (IMTX)?

Immatics N.V. (IMTX) has a market capitalization of $1.21B. The average daily trading volume is 362.73K, indicating the stock's liquidity and investor engagement.